Intrauterine devices in the conservative treatment of endometrial cancer: progress to date and potential for the future

References

• Ries LAG, Melbert D, Krapcho M et al. SEER Cancer Statistics Review, 1975–2005. National Cancer Institute, MD USA.
   Google Scholar
• Chiva de Agustín L, Lapuente Sastre F, Corraliza Galán V et al. Conservative management of patients with early endometrial carcinoma: a systematic review. Clin. Transl. Oncol.10, 155–162 (2008).
   PubMedGoogle Scholar
• Ramirez PT, Frumovitz M, Bodurka DC et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol. Oncol.95, 133–138 (2004).
   PubMed Web of Science ®Google Scholar
• Laurelli G, Di Vagno G, Scaffa C et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study. Gynecol. Oncol.120(1), 43–46 (2011).
   PubMed Web of Science ®Google Scholar
• Minig L, Franchi D, Boveri S et al. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann. Oncol.22(3), 643–649 (2011).
   PubMed Web of Science ®Google Scholar
• Emons G, Heyl W. Hormonal treatment of endometrial cancer. J. Cancer Res. Clin. Oncol.126, 619–623 (2000).
   PubMed Web of Science ®Google Scholar
• Tangjitgamol S, Manusirivithaya S, Hanprasertpong J. Fertility-sparing in endometrial cancer. Gynecol. Obstet. Invest.67(4), 250–268 (2009)
   PubMed Web of Science ®Google Scholar
• Vilos GA, Edris F, Al-Mubarak A et al. Hysteroscopic surgery does not adversely affect the long term prognosis of women with endometrial adenocarcinoma. J. Minim. Invasive Gynecol.14, 205–210 (2007).
   PubMed Web of Science ®Google Scholar
• Zaino R, Kauderer J, Liu Trimble C et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia. Cancer106, 804–811 (2006).
   PubMed Web of Science ®Google Scholar
• Frumovitz M, Gerhenson D. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev. Anticancer Ther.6, 27–32 (2006).
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Group Study. Cancer60, 2035–2041 (1987).
   PubMed Web of Science ®Google Scholar
• Zerbe MJ, Bristow R, Grumbine FC et al. Inability of preoperative computed tomography scans to accuracy predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol. Oncol.78, 67–70 (2000).
   PubMed Web of Science ®Google Scholar
• Horowitz NS, Dehdashti F, Herzog TJ et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol. Oncol.95, 546–551 (2004).
   PubMed Web of Science ®Google Scholar
• Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a metaanalysis. Radiology212, 711–718 (1999).
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Harada M, Sawada T et al. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology186, 495–501 (1993).
   PubMedGoogle Scholar
• Takeshima N, Hirai Y, Yano K et al. Ovarian metastasis in endometrial carcinoma. Gynecol. Oncol.70, 183–187 (1998).
   PubMed Web of Science ®Google Scholar
• Evans-Metcalf ER, Brooks SE, Reale FR et al. Profile of women 45 years of age and younger with endometrial cancer. Obstet. Gynecol.91, 349–354 (1998).
   PubMed Web of Science ®Google Scholar
• Walsh C, Holschneider C, Hoang Y et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol.106(4), 693–699 (2005).
   PubMed Web of Science ®Google Scholar
• Morice P, Fourchotte V, Sideris L et al. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol. Oncol.96, 245–248 (2005).
   PubMed Web of Science ®Google Scholar
• Yarali H, Bozdag G, Aksu T et al. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil. Steril.81, 214–216 (2004).
   PubMed Web of Science ®Google Scholar
• Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer71(Suppl. 4), 1467–1470 (1993).
   PubMed Web of Science ®Google Scholar
• Niwa K, Tagami K, Lian Z et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. Br. J. Obstet. Gynaecol.11, 317–320 (2005).
   Google Scholar
• Ota T, Yoshida M, Kimura M et al. Clinicopathologic study of uterine endometrial cancinoma in young women aged 40 years and younger. Int. J. Gynecol. Cancer15, 657–662 (2005).
   PubMed Web of Science ®Google Scholar
• Wang CB, Wang CJ, Chou HH et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer94, 2192–2198 (2002).
   PubMed Web of Science ®Google Scholar
• Dhar K, NeedhiRajan T, Koslowski M et al. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol. Oncol.97, 924–927 (2005).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wang H, Kelly RW et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum. Reprod.13, 1210–1217 (1998).
   PubMed Web of Science ®Google Scholar
• Vereide AB, Kaino T, Sager G et al. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol. Oncol.97, 740–750 (2005).
   PubMed Web of Science ®Google Scholar
• Montz FJ, Bristow BE, Bovicelli A et al. Intrauterine progesterone treatment of early endometrial cancer. Am. J. Obstet. Gynecol.186, 651–657 (2002).
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Ribeiro-Huguet P, de Andrade KC et al. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet. Gynecol. Scand.82(6), 580–582 (2003).
   PubMed Web of Science ®Google Scholar
• Giannopoulos T, Butler-Manuel S, Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol. Oncol.95(3), 762–764 (2004).
   PubMed Web of Science ®Google Scholar
• Vandenput I, Van Eygen K, Moerman P et al. Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature. Eur. J. Gynaecol. Oncol.30(3), 313–316 (2009).
   PubMedGoogle Scholar
• Tanmahasamut P, Wongwananuruk T. Challenging regimen for long-term conservative treatment of endometrial adenocarcinoma in young women: a case report and review of the literature. Case Rep. Oncol.3(3), 380–385 (2010).
   PubMedGoogle Scholar
• Flemming R, Sathiyathasan S, Jackson A. Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system. J. Minim. Invasive Gynecol.15(6), 771–773 (2008).
   PubMed Web of Science ®Google Scholar
• Abu J, Brown L, Ireland D. Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (mirena) in a 36-year-old woman. Int. J. Gynecol. Cancer16(3), 1445–1447 (2006).
   PubMed Web of Science ®Google Scholar
• Mazzon I, Corrado G, Masciullo V et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil. Steril.93(4), 1286–1289 (2010).
   PubMed Web of Science ®Google Scholar
• Mutter GL, Lin MC, Fitzgerald JT et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl Cancer Inst.92, 924–930 (2000).
   PubMed Web of Science ®Google Scholar
• Faquin WC, Fitzgerald JT, Boynton KA et al. Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas. Gynecol. Oncol.78, 152–157 (2000).
   PubMedGoogle Scholar
• Mutter GL, Baak JP, Crum CP et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J. Pathol.190, 462–469 (2000).
   PubMed Web of Science ®Google Scholar
• Signorelli M, Caspani G, Bonazzi C et al. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. BJOG116(1), 114–118 (2009).
   PubMedGoogle Scholar